Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1)

NCT03199989 is registered in ClinicalTrials.gov with Peking University Cancer Hospital & Institute as lead sponsor.

NCT NCT03199989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03199989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1)
Lead sponsor
Peking University Cancer Hospital & Institute
Phase
Phase 3
Overall status
Unknown status
Start date
June 1, 2017
Completion date
July 31, 2024
Enrollment
1,254 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant chemotherapy